Quantum Biopharma (QNTM) Non-Current Assets (2018 - 2026)

Quantum Biopharma (QNTM) has 9 years of Non-Current Assets data on file, last reported at $4.6 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 7.78% year-over-year to $4.6 million; the trailing twelve-month figure through Mar 2026 stood at $19.0 million (down 12.12% YoY), and the FY2025 full-year result was $4.7 million, down 7.58% from the prior year.
• Non-Current Assets retreated to $4.6 million in Q1 2026, from $4.7 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $20.6 million in Q4 2022 to a low of $4.6 million in Q1 2026.
• A 5-year average of $6.8 million and a median of $5.0 million in 2025 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets gained 20.73% in 2022 and plunged 68.92% in 2023, its largest moves.
• Tracing QNTM's Non-Current Assets over 5 years: stood at $20.6 million in 2022, then sank by 68.92% to $6.4 million in 2023, then dropped by 20.71% to $5.1 million in 2024, then decreased by 7.58% to $4.7 million in 2025, then retreated by 2.68% to $4.6 million in 2026.
• Business Quant data shows QNTM's Non-Current Assets at $4.6 million in Q1 2026, $4.7 million in Q4 2025, and $4.8 million in Q3 2025.